Valbiotis SA (EPA:ALVAL)
France flag France · Delayed Price · Currency is EUR
0.5530
0.00 (0.00%)
Oct 23, 2026, 9:14 AM CEST

Valbiotis Statistics

Total Valuation

Valbiotis has a market cap or net worth of EUR 13.08 million. The enterprise value is 9.50 million.

Market Cap13.08M
Enterprise Value 9.50M

Important Dates

The last earnings date was Monday, October 12, 2026.

Earnings Date Oct 12, 2026
Ex-Dividend Date n/a

Share Statistics

Valbiotis has 23.66 million shares outstanding.

Current Share Class 23.66M
Shares Outstanding 23.66M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 3.00%
Owned by Institutions (%) 7.83%
Float 22.95M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.78
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 7.10
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -51.21

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 3.46%
Revenue Per Employee 26,740
Profits Per Employee -163,840
Employee Count50
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -25.57% in the last 52 weeks. The beta is -0.14, so Valbiotis's price volatility has been lower than the market average.

Beta (5Y) -0.14
52-Week Price Change -25.57%
50-Day Moving Average 0.71
200-Day Moving Average 0.89
Relative Strength Index (RSI) 36.43
Average Volume (20 Days) 151,149

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Valbiotis had revenue of EUR 1.34 million and -8.19 million in losses.

Revenue1.34M
Gross Profit -704,000
Operating Income -7.99M
Pretax Income -8.19M
Net Income -8.19M
EBITDA -7.84M
EBIT -7.99M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) n/a
Book Value Per Share n/a
Working Capital n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.87 million and capital expenditures -8,000, giving a free cash flow of -8.88 million.

Operating Cash Flow -8.87M
Capital Expenditures -8,000
Depreciation & Amortization 150,500
Net Borrowing -484,000
Free Cash Flow -8.88M
FCF Per Share -0.38
Full Cash Flow Statement

Margins

Gross Margin -52.66%
Operating Margin -597.53%
Pretax Margin -612.72%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Valbiotis does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -62.62%
FCF Yield -67.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Analyst Forecast

The average price target for Valbiotis is 1.60, which is 189.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target 1.60
Price Target Difference 189.33%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1